Two recent studies have illustrated the utility of RainDance Technologies' MethylSeq Solution, a sequencing-based cytosine methylation analysis method that relies on the company's microdroplet PCR technology to amplify targeted sites in the genome.

"These two papers really showed quite well the application of our technology for doing targeted methylation analysis," Andy Watson, RainDance's vice president and chief marketing officer, told In Sequence. The studies demonstrate that the RainDance approach captures methylated regions of the genome more effectively than other targeted approaches and is more cost-effective than genome-wide methylated sequencing. Read more>>>>